Renvela (sevelamer carbonate) Powder for Oral Suspension
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
March 2016
CONTRAINDICATIONS
Renvela is contraindicated in patients with known hypersensitivity to sevelamer carbonate or to...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts
More News: Drugs & Pharmacology | Renvela